MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 98 filers reported holding MAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $944,568 | -37.8% | 303,718 | -11.0% | 0.01% | -50.0% |
| Q2 2023 | $1,518,878 | -13.1% | 341,321 | -5.9% | 0.01% | -22.2% |
| Q1 2023 | $1,747,654 | -9.6% | 362,584 | -1.4% | 0.02% | -18.2% |
| Q4 2022 | $1,933,512 | -22.7% | 367,588 | -4.9% | 0.02% | -29.0% |
| Q3 2022 | $2,501,000 | +36.5% | 386,602 | -2.7% | 0.03% | +47.6% |
| Q2 2022 | $1,832,000 | -36.5% | 397,382 | -2.6% | 0.02% | -27.6% |
| Q1 2022 | $2,886,000 | -34.1% | 408,167 | -4.6% | 0.03% | -32.6% |
| Q4 2021 | $4,379,000 | -19.4% | 428,021 | -4.3% | 0.04% | -25.9% |
| Q3 2021 | $5,430,000 | – | 447,288 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |